Clinical signs and laboratory markers in predicting progression to AIDS in HIV–1 infected patients

References

• Kaplan J E, Spira T J, Fishbein D B, Bozeman L H, Pinsky P F, Schonberger L B. A six‐year follow‐up of HIV‐infected homosexual men with lymphadenopathy. Evidence for an increased risk for developing AIDS after the third year of lymphadenopathy. JAMA 1988; 260: 2694–2697
   PubMedGoogle Scholar
• Hessol N A, Rutherford G W, Lifson A R, O'Malley P M, Doll L S, Darrow W W, Jaffe H W, Werdegar D. The natural history of HIV infection in a cohort of homosexual and bisexual men: a decade of follow‐up [abstract 4096]. In Programs and abstracts of the Fourth International Conference of AIDS. Swedish Ministry of Health and Social Affairs, Stockholm 1988
   Google Scholar
• Moss A R. Predicting who will progress to AIDS. Br Med J 1988; 297: 1067–1068
   PubMedGoogle Scholar
• Isaksson B, Albert J, Chiodi F, Furucrona A, Krook A, Putkonen P. AIDS two months after primary human immunodeficiency virus infection. J Infect Dis 1988; 158: 866–868
   PubMed Web of Science ®Google Scholar
• Polk B H, Fox R, Brookmeyer R, Kanchanaraksa S, Kaslow R, Visscher B, Rinaldo C, Phair J. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61–66
   PubMed Web of Science ®Google Scholar
• Goedert J J, Biggar R J, Melbye M, Mann D L, Wilson S, Gail M H, Grossman R J, DiGioia R A, Sanchez W C, Weiss S H, Blattner W A. Effect of T4 count and co‐factors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA 1987; 257: 331–334
   PubMed Web of Science ®Google Scholar
• Böttiger B, Morfeldt‐Månson L, Putkonen P, Nilsson B, Julander I, Biberfeld G. Predictive markers of AIDS: A follow‐up of lymphocyte subsets and HIV serology in a cohort of patient with lymphadenopathy. Scand J Infect Dis 1989; 21: 507–514
   PubMed Web of Science ®Google Scholar
• Lange J MA, Paul D A, Huisman H G, de Wolf F, van den Berg H, Coutinho R A, Danner S A, van der Noordaa J, Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J 1986; 293: 1459–1462
   PubMed Web of Science ®Google Scholar
• de Wolf F, Lange J MA, Houweling J TM, Coutinho R A, Schellekens P T, van der Noordaa J, Goudsmit J. Numbers of CD4 + cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988; 158: 615–622
   PubMedGoogle Scholar
• Pedersen C, Møller Nielsen C, Vestergaard B F, Gerstoft J, Krogsgaard K, Nielsen J O. Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. Br Med J 1987; 295: 567–569
   PubMed Web of Science ®Google Scholar
• de Wolf F, Goudsmit J, Paul D A, Lange J MA, Hooijkaas C, Schellekens P, Coutinho R A, van der Noordaa J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J 1987; 295: 569–572
   PubMedGoogle Scholar
• Morfeldt‐Månson L, Julander I, von Stedingk L ‐V, Wasserman J, Nilsson B. Elevated serum β‐2‐microglobulin – a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy. Infection 1988; 16: 109–110
   PubMedGoogle Scholar
• Moss A R, Bacchetti P, Osmond D, Krampf W, Chaisson R E, Stites D, Wilber J, Allain J ‐P, Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J 1988; 296: 745–750
   PubMed Web of Science ®Google Scholar
• Klein R S, Harris C A, Small C B, Moll B, Lesser M, Friedland G H. Oral candidiasis in high‐risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1988; 311: 354–358
   Google Scholar
• Greenspan D, Greenspan J S, Hearst N G, Pan L ‐Z, Conant M A, Abrams D I, Hollander H. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987; 155: 475–482
   PubMed Web of Science ®Google Scholar
• Morfeldt‐Månson L, Julander I, Nilsson B. Dermatitis of the face, yellow toe nail changes, hairy leukoplakia and oral candidiasis are clinical indicators of progression to AIDS/opportunistic infection in patients with HIV infection. Scand J Infect Dis 1989; 21: 497–505
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control: Persistent, generalized lymphadenopathy among homosexual males. MMWR 1982; 31: 249–250
   PubMedGoogle Scholar
• Centers for Disease Control: Update on acquired immune deficiency syndrome (AIDS) – United States. MMWR 1982; 31: 507–514
   PubMedGoogle Scholar
• Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987; 36(Suppl. 1S)
   Google Scholar
• Chiodi F, Bredberg‐Rådén U, Biberfeld G, Böttiger B, Albert J, Åsjö B, Fenyö E ‐M, Norrby E. Radioimmuno‐precipitation and Western blotting with sera of human immunodeficiency virus infected patients: A comparative study. AIDS Res Hum Retroviruses 1987; 3: 165–176
   PubMedGoogle Scholar
• Böttiger B, Blombäck M, Berntorp E, Egberg N, Nilsson I M, Schulman S, Stigendal L, Biberfeld G. HIV – serology and lymphocyte subsets in relation to therapy and clinical development in haemophiliacs. Eur J Haematol 1988; 41: 459–466
   PubMedGoogle Scholar
• Cox regression/ Cox DR. Regression model and life‐tables (with discussion). J R Statist Soc B 1972; 34: 187–220
   Web of Science ®Google Scholar
• Taylor J MG, Fahey J L, Detels R, Giorgi J V. CD4 percentage, CD4 number, and CD4: CD8 ratio in HIV infection: Which to choose and how to use. J AIDS 1989; 2: 114–124
   PubMed Web of Science ®Google Scholar
• Cooper D A, Tindall B, Wilson E J, Imrie A A, Penny R. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis 1988; 157: 889–896
   PubMed Web of Science ®Google Scholar
• Allain J ‐P, Laurian Y, Paul D A, Verroust F, Leuther M, Gazengel C, Senn D, Larrieu M ‐J, Bosser C. Long‐term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia – potential clinical importance. N Engl J Med 1987; 317: 114–121
   PubMedGoogle Scholar
• Carne C A, Weller I VD, Loveday C, Wadler M. From persistent generalised lymphadenopathy to AIDS: Who will progress?. Br Med J 1987; 294: 868–869
   PubMedGoogle Scholar
• Lindhardt B O, Ulrich K, Kusk P, Hofmann B. Serological response in patients with chronic asymptomatic human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 1988; 7: 394–399
   PubMedGoogle Scholar
• Lefrère J ‐J, Salmon D, Doinel C, Rouger P, Courouce A ‐M, Lambin P, Salmon C. Sedimentation rate as a predictive marker in HIV infection. AIDS 1988; 2: 63–64
   PubMedGoogle Scholar
• Zolla‐Pazner S, Villiam D, El‐Sadr W, Marmor M, Stahl R. Quantitation of β‐2‐microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome. JAMA 1984; 251: 2951–2955
   PubMed Web of Science ®Google Scholar
• Lacey C JN, Forbes M A, Waugh M A, Cooper E H, Hambling M H. Serum β‐2‐microglobulin and human immunodeficiency virus infection. AIDS 1987; 1: 123–127
   PubMedGoogle Scholar
• Heering P, Arning M. Neopterin and β‐2‐microglobulin as markers for AIDS. Lancet 1987; 1: 281
   PubMedGoogle Scholar
• Archibald D W, Barr C E, Torosian J P, McLane M F, Essex M. Four‐year prospective study of homosexual men: Correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus. J Infect Dis 1987; 155: 789–796
   PubMedGoogle Scholar
• Lui K J, Darrow W W, Rutherford G W, III. A model‐based estimate of the mean incubation period for AIDS in homosexual men. Science 1988; 240: 1333–1335
   PubMed Web of Science ®Google Scholar